Botanix Pharmaceuticals (ASX:BOT) crashed over 50% back on Tuesday after an update that left investors disappointed. A crash of this magnitude would suggest the FDA knocked back its drug or that it failed a clinical trial.
With Botanix having commercialised its treatment, neither was the case, so it'd have to be a pretty bad sales update.…
News
Israel’s strikes on Iran, and the subsequent responses, led to the typical "risk off" moves professional investors usually make when faced with uncertainty. But what exactly does "risk off" mean and how relevant is it for retail investors? Should you be risk off too or should you ride out geopolitical uncertainty?
Few would've predicted Israel would've…
The US stock market has seen turbulent times over the past few years. From the COVID-19 pandemic’s market shock to inflation fears, interest rate hikes, and geopolitical instability, investors have been navigating through one storm after another. As we move into June 2025, one key question stands out for investors: Has the storm finally passed?…
As the end of the financial year (EOFY) approaches on 30 June, let's take a look at some of the most important Tax Deductions For Investors in Australia.
The EOFY is when many investors assess their finances and maximise available tax benefits. While common deductions, such as mortgage interest on investment properties and depreciation, and brokerage…
Firstwave Cloud Technology (ASX:FCT) and Amazon have just announced that the pair are teaming up to deploy the former company's product suite onto the latter's AWS marketplace. Shares have gained over 20% this morning off the back of this news.
Recap of Firstwave Cloud Technology
Firstwave is an ASX-listed technology company. Its historical specialty has been…
Tesla has captured the imagination of investors and the public alike over the past decade. From its humble beginnings as a startup aiming to revolutionise the automotive industry, Tesla has become one of the most influential companies in the world. As we move deeper into 2025, many investors are asking: Is Tesla stock still a…
2025 has been, and will continue to be, a big year for Proteomics, which has just launched PromarkerD onto the Australian market. Before this year is over, the company anticipates launching another 2 tests - PromarkerEndo and PromarkerEso; and is eyeing off the US market too.
Recap of Proteomics (ASX:PIQ)
For investors that are new to…
Ventia Services (ASX:VNT) listed on the ASX in November 2021 at $1.5bn and is now capitalised at $4bn. Since listing it has recorded persistent revenue and profit growth. There is very little to complain about from a financial perspective, and it may still be undervalued. However, things aren't completely perfect for it.
Overview of Ventia…
ESG investing is becoming increasingly popular with investors. But as this happens, it begs the question as to just how you can tell if an applicable stock or fund is ESG friendly?
So how can I tell if my stock or fund is ESG compliant?
As tough as it is to disappoint our readers, there is no…
The US credit downgrade in 2025 has sent ripples through global financial markets, raising serious questions for investors worldwide. When the world’s largest economy loses its top-tier credit rating, it forces a reckoning: Are we facing a wave of sell-offs, or should investors instead seek refuge in safe havens? This event is more than just…
